Advertisement

Quality of Life Following Glaucoma Drainage Device Surgery

  • Bernardo de Padua Soares Bezerra
  • Syril Dorairaj
  • Fabio Nishimura Kanadani
Chapter

Abstract

Understanding the impact of the disease and its treatment on the patient’s quality of life is an important aspect of medical care. Good quality of life is sought after by the vast majority of patients.

References

  1. 1.
    Beauchamp GR, Felius J, Stager DR, Beauchamp CL. The utility of strabismus in adults. Trans Am Ophthalmol Soc. 2005;103:164–71.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Brown GC, Brown MM, Stein JD, Roth Z, Campanella J, Beauchamp GR. The burden of age-related macular degeneration. Trans Am Ophthalmol Soc. 2005;103:180–93.Google Scholar
  3. 3.
    Medeiros F, Gracitelli C, Boer E, Weinreb R, Zangwill L, Rosen P. Longitudinal changes in quality of life and rates of progressive visual field loss in glaucoma patients. Ophthalmology. 2015;122:293–301.CrossRefGoogle Scholar
  4. 4.
    Spaeth G, Walt J, Keener J. Evaluation of quality of life for patients with glaucoma. Am J Ophthalmol. 2006;141(1 Suppl):S3–S14.CrossRefGoogle Scholar
  5. 5.
    Appleby J, Devlin N. Measuring success in the NHS. Using patient-assessed health outcomes to manage the performance of healthcare providers. Dr. Foster Ethics Committee London, UK; November 2004. http://www.staff.city.ac.uk/n.j.devlin/measuring%20success%20in%20the%20NHS.pdf. Accessed 10 Jul 2016.
  6. 6.
    Varma R, Richman EA, Ferris FL III, Bressler NM. Use of patient-reported outcomes in medical product development: a report from the 2009NEI/FDA Clinical Trial Endpoints Symposium. Invest Ophthalmol Vis Sci. 2010;51(12):6095–103.CrossRefGoogle Scholar
  7. 7.
    Black N. Patient reported outcome measures could help transform healthcare. BMJ. 2013;346:f167.CrossRefGoogle Scholar
  8. 8.
    Parrish RK II, Gedde SJ, Scott IU, et al. Visual function and quality of life among patients with glaucoma. Arch Ophthalmol. 1997;115(11):1447–55.CrossRefGoogle Scholar
  9. 9.
    Jampel HD. Glaucoma patients’ assessment of their visual function and quality of life. Trans Am Ophthalmol Soc. 2001;9:301–17.Google Scholar
  10. 10.
    Glen FC, Crabb DP, Smith ND, Burton R, Garway-Heath DF. Do patients with glaucoma have difficulty recognizing faces? Invest Ophthalmol Vis Sci. 2012;53(7):3629–37.CrossRefGoogle Scholar
  11. 11.
    Kotecha A, O’Leary N, Melmoth D, Grant S, Crabb DP. The functional consequences of glaucoma for eye-hand coordination. Invest Ophthalmol Vis Sci. 2009;50(1):203–13.CrossRefGoogle Scholar
  12. 12.
    McGwin G Jr, Mays A, Joiner W, et al. Is glaucoma associated with motor vehicle collision involvement and driving avoidance? Invest Ophthalmol Vis Sci. 2004;45(11):3934–9.CrossRefGoogle Scholar
  13. 13.
    Altangerel U, Spaeth GL, Steinmann WC. Assessment of function related to vision (AFREV). Ophthalmic Epidemiol. 2006;13(1):67–80.CrossRefGoogle Scholar
  14. 14.
    Lorenzana L, Lankaranian D, Dugar J, et al. A new method of assessing ability to perform activities of daily living: design, methods and baseline data. Ophthalmic Epidemiol. 2009;16(2):107–14.CrossRefGoogle Scholar
  15. 15.
    Richman J, Lorenzana LL, Lankaranian D, et al. Relationships in glaucoma patients between standard vision tests, quality of life, and ability to perform daily activities. Ophthalmic Epidemiol. 2010;17(3):144–51.CrossRefGoogle Scholar
  16. 16.
    Waisbourd M, Parker S, Ekici F, et al. A prospective, longitudinal, observational cohort study examining how glaucoma affects quality of life and visually-related function over 4 years: design and methodology. BMC Ophthalmol. 2015;15:91.CrossRefGoogle Scholar
  17. 17.
    Musch DC, Lichter PR, Guire KE, Standardi CL. The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999;106(4):653–62.CrossRefGoogle Scholar
  18. 18.
    Kotecha A, Feuer WJ, Barton K, Gedde SJ, The Tube Versustrabeculectomy Study Group. Quality of life in the tube versus trabeculectomy study. Am J Ophthalmol. 2017;176:228–35.CrossRefGoogle Scholar
  19. 19.
    Janz NK, Wren PA, Lichter PR, et al. Quality of life in newly diagnosed glaucoma patients: The Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2001;108(5):887–97. discussion 898.CrossRefGoogle Scholar
  20. 20.
    Baus S. Psychological aspects of visual impairment. Br J Vis Impair. 1999;17:41–4.CrossRefGoogle Scholar
  21. 21.
    Owsley C, McGwin G Jr. Depression and the 25-item National Eye Institute Visual Function Questionnaire in older adults. Ophthalmology. 2004;111(12):2259–64.CrossRefGoogle Scholar
  22. 22.
    Richman J, Lorenzana L, Lankaranian D, Dugar J, Mayer J, Wizov S, Spaeth G. Relationships in glaucoma patients between standard vision tests, quality of life, and ability to perform daily activities. Ophthalmic Epidemiol. 2010;17(3):144–51.CrossRefGoogle Scholar
  23. 23.
    Waisbourd M, Parker S, Ekici F, Martinez P, Murphy R, Scully K, Wizov S, Hark L, Spaeth G. A prospective, longitudinal, observational cohort study examining how glaucoma affects quality of life and visually-related function over 4 years: design and methodology. BMC Ophthalmol. 2015;15:91.CrossRefGoogle Scholar
  24. 24.
    Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119(7):1050–8.CrossRefGoogle Scholar
  25. 25.
    Gutierrez P, Wilson MR, Johnson C, et al. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol. 1997;115:777–84.CrossRefGoogle Scholar
  26. 26.
    Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407–15.CrossRefGoogle Scholar
  27. 27.
    Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61(2):102–9.CrossRefGoogle Scholar
  28. 28.
    Jampel HD, Schwartz A, Pollack I, et al. Glaucoma patients’ assessment of their visual function and quality of life. J Glaucoma. 2002;11(2):154–63.CrossRefGoogle Scholar
  29. 29.
    Friedman SM, Munoz B, Rubin GS, et al. Characteristics of discrepancies between self-reported visual function and measured reading speed. Salisbury Eye Evaluation Project Team. Invest Ophthalmol Vis Sci. 1999;40(5):858–64.PubMedGoogle Scholar
  30. 30.
    Lee BL, Gutierrez P, Gordon M, et al. The glaucoma symptom scale: a brief index of glaucoma-specific symptoms. Arch Ophthalmol. 1998;116:861–6.CrossRefGoogle Scholar
  31. 31.
    Noe G, Ferraro J, Lamoureux E, Rait J, Keeffe JE. Associations between glaucomatous visual field loss and participation in activities of daily living. Clin Exp Ophthalmol. 2003;31:482–6.CrossRefGoogle Scholar
  32. 32.
    Viswanathan AC, McNaught AI, Poinoosawmy D, et al. Severity and stability of glaucoma: patient perception compared with objective measurement. Arch Ophthalmol. 1999;117:450–4.CrossRefGoogle Scholar
  33. 33.
    Nelson P, Aspinall P, Papasouliotis O, Worton B, O’Brien C. Quality of life in glaucoma and its relationship with visual function. J Glaucoma. 2003;12:139–50.CrossRefGoogle Scholar
  34. 34.
    Lisboa R, Chun YS, Zangwill LM, et al. Association between rates of binocular visual field loss and vision-related quality of life in patients with glaucoma. JAMA Ophthalmol. 2013;131:486–94.CrossRefGoogle Scholar
  35. 35.
    Jampel HD, Friedman DS, Quigley H, Miller R. Correlation of the binocular visual field with patient assessment of vision. Invest Ophthalmol Vis Sci. 2002;43(4):1059–67.PubMedGoogle Scholar
  36. 36.
    Okamoto M, Sugisaki K, Murata H, et al. Impact of better and worse eye damage on quality of life in advanced glaucoma. Sci Rep. 2014;4:4144.CrossRefGoogle Scholar
  37. 37.
    Mills RP, Janz NK, Wren PA, Guire KE. Correlation of visual field with quality-of-life measures at diagnosis in the Collaborative Initial Glaucoma Treatment Study (CIGTS). J Glaucoma. 2001;10(3):192–8.CrossRefGoogle Scholar
  38. 38.
    Feinstein AR, Josephy BR, Wells CK. Scientific and clinical problems in indexes of functional disability. Ann Intern Med. 1986;105(3):413–20.CrossRefGoogle Scholar
  39. 39.
    Kroenke K, Spitzer R. Gender differences in the reporting of physical and somatoform symptoms. Psychosom Med. 1998;60:150–5.CrossRefGoogle Scholar
  40. 40.
    Verbrugge LM, Patrick DL. Seven chronic conditions: their impact on US adults’ activity levels and use of medical services. Am J Public Health. 1995;85:173–82.CrossRefGoogle Scholar
  41. 41.
    Gedde SJ, Singh K, Schiffman JC, Feuer WJ. The Tube Versus Trabeculectomy Study: interpretation of results and application to clinical practice. Curr Opin Ophthalmol. 2012;23(2):118–26.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Bernardo de Padua Soares Bezerra
    • 1
  • Syril Dorairaj
    • 2
  • Fabio Nishimura Kanadani
    • 3
  1. 1.Royal Victorian Eye and Ear HospitalMelbourneAustralia
  2. 2.Mayo ClinicJacksonvilleUSA
  3. 3.Instituto de Olhos Ciencias MedicasBelo HorizonteBrazil

Personalised recommendations